[1]
Kumari Sharmila et al. 2025. SERUM CYTOKERATIN-18 AS A NON-INVASIVE BIOMARKER IN NON-ALCOHOLIC FATTY LIVER DISEASE DIAGNOSIS. Journal of Population Therapeutics and Clinical Pharmacology. 32, 6 (Jul. 2025), 1100–1105. DOI:https://doi.org/10.53555/5zcang26.